| Autore: |
Tikkanen Ritva
|
| Titolo: |
Mitogen Activated Protein Kinases : Functions in Signal Transduction and Human Diseases
|
| Pubblicazione: |
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica: |
1 online resource (276 p.) |
| Soggetto topico: |
Biology, life sciences |
| |
Research & information: general |
| Soggetto non controllato: |
angiogenesis |
| |
antimicrobial peptide |
| |
aortic valve sclerosis |
| |
aortic valve stenosis |
| |
apoptosis |
| |
atherosclerosis |
| |
bone remodeling |
| |
bronchopulmonary dysplasia |
| |
cancer |
| |
cancer signaling |
| |
cecropin A |
| |
cell cycle |
| |
Compatibility |
| |
CR |
| |
cytokines |
| |
DAPK |
| |
DOK4 |
| |
downregulation |
| |
DUSP1 |
| |
ERK |
| |
ERK1/2 |
| |
erlotinib |
| |
extracellular signal-regulated kinase 5 (ERK5) |
| |
extracellular signal-regulated kinases 1/2 |
| |
FGF-induced signaling |
| |
FR180204 |
| |
FRS2 |
| |
gastric ulcer |
| |
HPAECs |
| |
hyperoxia |
| |
infantile myofibromatosis |
| |
inflammation |
| |
JNK |
| |
JNKs |
| |
Kv4.2 |
| |
MAPK |
| |
MAPK kinetics |
| |
MAPK/PI3K/Akt signaling pathway |
| |
MEK/ERK signaling |
| |
metabolic profiling |
| |
mitochondria |
| |
mitochondrial dysfunction |
| |
mitogen-activated protein kinase pathway (MAPK pathway) |
| |
mitogen-activated protein kinases (MAPKs) |
| |
MKK4 |
| |
MKK7 |
| |
N-heterocyclic carbene |
| |
n/a |
| |
naphthalimide-metal complex conjugates |
| |
neuro-inflammation |
| |
neurodegeneration |
| |
NF-κB |
| |
osteoclast differentiation |
| |
oxidative stress |
| |
p38 |
| |
p38 MAPK |
| |
p38 MAPKs |
| |
p53 |
| |
Parkinson's disease |
| |
PC12 cells |
| |
phosphorylation |
| |
platelet-derived growth factor receptor |
| |
porcine intestinal epithelial cell |
| |
protein kinase inhibitors |
| |
protein tyrosine phosphatase interacting protein 51 (PTPIP51) |
| |
protein-protein interaction (PPI) |
| |
psoriasis |
| |
PTPN6 |
| |
Rabdosia inflexa |
| |
reactive oxygen species |
| |
receptor tyrosine kinases |
| |
ROS |
| |
SIRT1 |
| |
SIRT2 |
| |
SR |
| |
SRC |
| |
sunitinib |
| |
T2DM |
| |
targeted therapy |
| |
tight junction protein |
| |
U0126 |
| Persona (resp. second.): |
Nikolic-PatersonDavid |
| |
TikkanenRitva |
| Sommario/riassunto: |
Mitogen-activated protein kinases (MAPK) are a large family of enzymes that function as signal transducers to regulate a diverse range of physiological responses. However, signaling via extracellular signal-regulated kinase (ERK), c-Jun amino terminal kinase (JNK), and p38 MAPK also underpin many disease processes. This Special Issue provides new insights into how MAPK signaling contributes to specific pathological processes across a range of conditions, including disorders of lung development, type 2 diabetes, proliferative skin diseases, cardiovascular diseases, and neurological diseases. |
| Altri titoli varianti: |
Mitogen Activated Protein Kinases |
| Titolo autorizzato: |
Mitogen Activated Protein Kinases  |
| Formato: |
Materiale a stampa  |
| Livello bibliografico |
Monografia |
| Lingua di pubblicazione: |
Inglese |
| Record Nr.: | 9910557405603321 |
| Lo trovi qui: | Univ. Federico II |
| Opac: |
Controlla la disponibilità qui |